Recursion Pharmaceuticals (RXRX): 10 Unrivaled Penny Stocks to Buy Now

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) reported first-quarter gross of $6.47 cardinal connected May 7, beneath expert statement estimates of $15.78 million. The institution ended the 4th with astir $665.2 cardinal successful cash, currency equivalents, and restricted cash, compared with $753.9 cardinal astatine the extremity of 2025, portion maintaining expectations that its currency runway volition widen into aboriginal 2028. CEO Najat Khan stated that the institution continues seeing beardown execution crossed its portfolio, including encouraging archetypal information and pharmacokinetic information from REC-1245 and the archetypal diligent dosing successful REC-4539. Management emphasized that the advancement demonstrates the company’s quality to construe biologic and chemic insights generated by its AI-driven level into differentiated clinical-stage programs.

Earlier, connected April 30, JPMorgan Chase & Co. lowered its terms people connected Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) to $10 from $11 portion maintaining an Overweight standing connected the shares. The firm’s continued affirmative stance reflects assurance successful the company’s semipermanent AI-enabled cause find level contempt near-term fiscal pressures and ongoing objective improvement costs.

Recursion Pharmaceuticals is simply a clinical-stage TechBio institution that integrates artificial intelligence, instrumentality learning, and automation to industrialize cause find and development. Founded successful 2013 and headquartered successful Salt Lake City, the institution focuses connected decoding biology to place treatments for uncommon diseases, oncology, and different areas with important unmet aesculapian needs. Its proprietary level combines large-scale biologic information investigation with precocious automation to accelerate therapeutic discovery.

The company’s important currency presumption and expanding objective pipeline whitethorn supply flexibility to proceed advancing aggregate AI-driven cause programs contempt ongoing improvement expenses.

While we admit the imaginable of RXRX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Under-the-Radar Stocks That Are On Fire Right Now and 7 Best Hardware Stocks to Buy for the AI PC Revolution.

Disclosure: None.  Follow Insider Monkey connected Google News.